Medical Device Development in Asia-Pacific
The challenges and opportunities of patient recruitment and retention
Asia-Pacific is experiencing unprecedented growth in the medical device space, forecasting an 8 percent CAGR, reaching USD$133 billion in 2020. With devices having a much shorter life-cycle than biopharma products, speed is of the essence in the conduct of medical device trials. An effective patient recruitment and retention strategy can propel medical device trials in the right direction by addressing cultural and organizational challenges and opportunities.
This paper discusses the value that Asia-Pacific trial sites can provide, the challenges in patient recruitment and retention that sponsors may potentially face when running studies in the region, and how partnering mitigates these potential downsides.